The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAAA.L Regulatory News (AAA)

  • There is currently no data for AAA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible loan and issue of warrants

30 Nov 2020 07:00

RNS Number : 8401G
All Active Asset Capital Limited
30 November 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 ('MAR').

 

30 November 2020

 

All Active Asset Capital Limited

('AAA' or 'the Company')

Convertible loan to MESH Holdings plc

 

Issue of AAA warrants exercisable at 15p

 

Convertible loan

 

AAA is pleased to announce that it has agreed the terms for providing a secured convertible €3.0m loan ('the Loan') to MESH Holdings plc ('MESH').  

 

The Loan will have a duration of two years and will yield annual interest of 5.0% payable on repayment. At the sole discretion of AAA, the Loan can be converted into new ordinary shares in MESH at a price of 40p per MESH share. The Loan will have a first ranking security interest over the shares of Sentiance NV ('Sentiance') that are held by MESH and will be funded through the cash resources held by the Company. The Loan may, in certain circumstances, be repayable to AAA prior to the repayment date.

 

MESH intends to use the funds from the Loan to make a loan of €3,000,000 to Sentiance, with these funds ultimately being used by MESH to subscribe for new shares in Sentiance. When complete this is expected to increase MESH's shareholding in Sentiance from its current 16.6% to 20.5%.

 

Sentiance is an emerging organisation within the fields of behavioural, ethical artificial intelligence and machine learning, with its 'Motion Intelligence' and 'Behavioural Change Platform' technologies. Sentiance has recently announced new partnerships, and extended partnerships and contracts with well-known international businesses, including several Fortune 500 customers.

 

MESH is an investing company which aims to incubate emerging technology brands that are conceived to provide people with more meaningful experiences. For the year ended 30 September 2019, MESH's audited loss for the year was £13,859,000 (2018: £337,000) and audited net assets as at 30 September 2019 were £16,636,000 (2018: £493,000).

Issue of warrants exercisable at 15p

 

On 14 May 2020, AAA was granted options ('the Options') to acquire a total of 20,500,000 warrants ('the ASLR Warrants') in Asimilar Group plc ('ASLR'), all of which have now lapsed following the expiry of the ASLR Warrants on 31 October 2020 and 30 September 2020 respectively.

 

The Board of AAA ('the Board') originally entered into the Option arrangement with the intention of exercising the Options at an appropriate time. In recognition of AAA not exercising the Options prior to their lapse dates, the Board now considers that it is appropriate that the underlying holders of the ASLR Warrants are granted a total of 49.2 million warrants to subscribe for new ordinary shares in AAA ('AAA Warrants').

 

The AAA Warrants are exercisable at 15p per Ordinary Share for a period of 18 months from the date of grant, being today's date. The exercise price of the AAA Warrants represents a significant premium to AAA's closing mid-market price on 27 November 2020 and the exercise in full of the AAA Warrants would raise £7.38 million for the Company. The AAA Warrants shall not be admitted to trading on AIM or any other stock market, but will be transferable.

 

Rodger Sargent, Executive Director of AAA, commented, "We are delighted to have gained this initial indirect exposure to MESH's interest in Sentiance through the convertible loan with MESH. Sentiance continues to make significant progress with its award-winning technology. We believe next year will be a breakthrough year for Sentiance, as it moves from a stealth, proof of concept mode towards becoming a global technology player."

 

 

For further information:

All Active Asset Capital Limited

James Normand, Non-Executive Chairman

Rodger Sargent, Executive Director

www.aaacap.com 

 

Allenby Capital Limited (Nominated Adviser and Broker)

Alex Brearley / Nick Athanas

T: +44 (0) 203 328 5656

www.allenbycapital.com 

Buchanan (Financial PR)

Richard Oldworth / Chris Lane / Toto Berger

T: +44 (0) 207 466 5000

E: AAAC@buchanan.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGUAGUPUGBB
Date   Source Headline
14th Jul 20208:05 amRNSStatement re Announcement by Asimilar
9th Jul 20201:10 pmRNSBoard Appointment
2nd Jul 20209:20 amRNSBlock admission application
30th Jun 20203:10 pmRNSStatement re Asimilar Interim Results
26th Jun 20201:22 pmRNSExtension of reporting deadline & portfolio update
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
19th Jun 20202:41 pmRNSHolding(s) in Company
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:35 pmRNSPrice Monitoring Extension
17th Jun 202012:46 pmRNSHolding(s) in Company
16th Jun 20204:41 pmRNSSecond Price Monitoring Extn
16th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20209:30 amRNSAdmission of Placing Shares and Board Change
12th Jun 202011:30 amRNSResult of Extraordinary General Meeting
28th May 20207:00 amRNSBoard changes
22nd May 20208:41 amRNSNotice of Extraordinary General Meeting
14th May 20204:40 pmRNSSecond Price Monitoring Extn
14th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20204:22 pmRNSRevised placing to raise £1.2 million
14th May 20202:06 pmRNSSecond Price Monitoring Extn
14th May 20202:01 pmRNSPrice Monitoring Extension
14th May 202012:19 pmRNSOptions over warrants in Asimilar Group plc
7th May 20205:42 pmRNSFurther re. proposed conditional placing
28th Apr 20207:00 amRNSUpdate on proposed placing to raise £1.26 million
17th Apr 20202:57 pmRNSHolding(s) in Company
17th Apr 20202:52 pmRNSHolding(s) in Company
17th Apr 20202:50 pmRNSHolding(s) in Company
16th Apr 202011:53 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 20203:24 pmRNSProposed conditional placing
30th Mar 202012:10 pmRNSInvestment in shares in Asimilar Group Plc
26th Mar 20201:25 pmRNSHolding(s) in Company
20th Mar 20202:15 pmRNSInvestment in warrants in Asimilar Group Plc
10th Mar 202012:54 pmRNSChange of Board Roles
28th Feb 20205:00 pmRNSTotal Voting Rights
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202011:13 amRNSHolding(s) in Company
24th Feb 202012:24 pmRNSResult of Extraordinary General Meeting
10th Feb 202011:01 amRNSAvailability of circular
5th Feb 20203:49 pmRNSProposed conditional placing to raise £200,000
31st Jan 202012:17 pmRNSBoard changes
15th Oct 20192:10 pmRNSChange of Name
10th Oct 201911:09 amRNSResult of Extraordinary General Meeting
30th Sep 20195:00 pmRNSTotal Voting Rights
24th Sep 20191:51 pmRNSInterim Results for the period ended 30 June 2019
23rd Sep 20191:00 pmRNSCompletion of placing and other matters
20th Sep 201911:04 amRNSAvailability of circular
17th Sep 201911:19 amRNSPlacing to raise £125,000 and other matters
30th Jul 20191:39 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.